Insulin glargine and lixisenatide

  • Biologic
  • Soliqua 100/33

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Insulin glargine and lixisenatide: storage and handling

Refrigerate
Yes, as the label states
Label statement
Prior to first use, SOLIQUA 100/33 pen should be stored in a refrigerator, 36°F–46°F (2°C–8°C).
Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
at or below 25°C (77°F)
Label statement
After first use, store at room temperature up to 77°F (25°C).
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 25°C (77°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

After first use, store at room temperature up to 77°F (25°C).
Discard SOLIQUA 100/33 if it has been frozen.
Discard pen 28 days after first use.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-633-1610 (the number printed on the label) about this product.

Where the label prints this number
Need help? If you have any questions about your pen or about diabetes, ask your healthcare provider, go to www.soliqua100-33.com or call sanofi-aventis at 1-800-633-1610 .
All storage statements on the label (8)
  • Prior to first use, SOLIQUA 100/33 pen should be stored in a refrigerator, 36°F–46°F (2°C–8°C).
  • Do not freeze.
  • Discard SOLIQUA 100/33 if it has been frozen.
  • Protect from light.
  • After first use, store at room temperature up to 77°F (25°C).
  • Replace the pen cap after each use to protect from light.
  • Discard pen 28 days after first use.
  • Remove the needle after each injection and store the SOLIQUA 100/33 pen without a needle attached.

FDA label version 25, effective March 18, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

92%of plans list it
0%of those: prior authorization
0%step therapy
96%quantity limit
0%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.